Inflammatory cytokines and immune signalling in heart failure: mechanisms, models, and emerging therapies
Cardiovascular Research · 10.10.2026 · 122 (14) · 1901-1921
DOI: 10.1093/cvr/cvag172 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 18.08.2026. Verfasst von Guiomar Mendieta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR SANT PAU), CIBERCV, Universitat Autònoma de Barcelon…. Hauptthemen laut MEDLINE: Heart Failure, Cytokines, Inflammation Mediators, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 301 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk A/S.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Inflammation plays a central role in the pathophysiology of heart failure (HF), and contributes to disease progression, morbidity, and mortality. However, the relationships between inflammatory cytokines and different HF subtypes are complex, heterogeneous, and bidirectional. In this review, we examine inflammatory pathways, biomarker profiles, and comorbidities in HF with reduced, mildly reduced, and preserved ejection fraction and summarize evidence on the use of high-sensitivity C-reactive protein as a biomarker for systemic inflammation in HF. We provide insights into emerging methodologies for biomarker discovery in HF and discuss the use of animal models to elucidate underlying mechanisms and test potential treatment strategies. Finally, we provide an overview of the therapeutic landscape, touching on past challenges and future opportunities for the development of targeted anti-inflammatory therapies in HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR SANT PAU), CIBERCV, Universitat Autònoma de Barcelona, Carrer de Sant Quintí, 89, Barcelona 08025, Spain.
- Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
- Department of Medicine, Cardiology Unit, Karolinska Institutet, Stockholm, Sweden.
- Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
ORCID-Profile: Guiomar Mendieta, Gianluigi Pironti, Jasper Tromp
Förderung
- Novo Nordisk A/S
Zitieren
APA
Mendieta, G., Pironti, G., Tromp, J., & Lund, L. H. (2026). Inflammatory cytokines and immune signalling in heart failure: mechanisms, models, and emerging therapies. Cardiovascular Research, 122(14), 1901-1921. https://doi.org/10.1093/cvr/cvag172
Vancouver
Mendieta G, Pironti G, Tromp J, Lund LH. Inflammatory cytokines and immune signalling in heart failure: mechanisms, models, and emerging therapies. Cardiovascular Research. 2026;122(14):1901-1921. doi:10.1093/cvr/cvag172
BibTeX
@article{Mendieta2026,
author = {Mendieta, Guiomar and Pironti, Gianluigi and Tromp, Jasper and Lund, Lars H},
title = {Inflammatory cytokines and immune signalling in heart failure: mechanisms, models, and emerging therapies},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {14},
pages = {1901--1921},
doi = {10.1093/cvr/cvag172}
}
EUVIMED